Today, May 9, 2021, Turkmenistan received a significant batch of the COVID-19 vaccine, ConoVas, created by Sinovas (PRC). The efficacy and safety of the vaccine have been proven by a number of clinical trials in different states.
Recall the important details of interaction in the health care industry, including jointly confronting the global pandemic, were discussed by the heads of Turkmenistan and China during a telephone conversationThe discussion of the prospects for bilateral cooperation continued today. The discussion of the prospects for bilateral cooperation was continued in the framework of today's Turkmen Foreign Minister Rashid Meredov talks with Chinese Deputy Foreign Minister Le Yucheng. Representatives of Turkmenistan and China unanimously expressed their intention to cooperate closely and share their accumulated experience in the fight against the COVID-19 pandemic, noting that only a unified effort can have a qualitative effect in the fight against the COVID-19 pandemic.
Vaccines received from China were delivered for preservation to the Center for Public Health and Nutrition of the State Epidemic Service of the Ministry of Health, Ashgabat and Velaiat Sanitary and Epidemiological Facility.
To strengthen the immune status of Turkmenistanis in view of the global world pandemic, our state has previously received Sputnik V and EpiwakCona from the Russian Federation and BIOwak from the PRC.
Delivered vaccines are stored in special warehouses in a "cold chain," strictly according to WHO recommendations.
A sufficient number of vaccines have arrived to allow vaccination against COVID-19 to begin in Turkmenistan for citizens of the most at-risk groups.